Comparative effectiveness of ledipasvir/sofosbuvir ± ribavirin vs. ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in 6961 genotype 1 patients treated in routine medical practice.
about
Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis CComparative treatment effectiveness of direct acting antiviral regimens for hepatitis C: Data from the Veterans administration.Interferon-free treatments in patients with hepatitis C genotype 1-4 infections in a real-world settingEffectiveness of dasabuvir/ombitasvir/paritaprevir/ritonavir for hepatitis C virus in clinical practice: A population-based observational study.Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access program.Engagement in Care of High-Risk Hepatitis C Patients with Interferon-Free Direct-Acting Antiviral Therapies.Hepatitis C: efficacy and safety in real life.In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered.Ombitasvir and paritaprevir boosted with ritonavir and combined with dasabuvir for chronic hepatitis C.Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna.The efficacy and safety of direct acting antiviral treatment and clinical significance of drug-drug interactions in elderly patients with chronic hepatitis C virus infection.Optimal timing for hepatitis C therapy in US patients eligible for liver transplantation: a cost-effectiveness analysis.Sustained virological response to ombitasvir/paritaprevir/ritonavir and dasabuvir treatment for hepatitis C: Real-world data from a large healthcare provider.Treating hepatitis C in the elderly: pharmacotherapeutic considerations and developments.Impact of Direct Acting Antiviral Therapy for Treatment of Hepatitis C Genotypes 1, 3 and 4: A Real Life Experience from India.No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients.Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents.Clinical utility of ledipasvir/sofosbuvir in the treatment of adolescents and children with hepatitis CSofosbuvir based regimens in the treatment of chronic hepatitis C genotype 1 infection in African-American patients: a community-based retrospective cohort study
P2860
Q28552691-56890582-EB96-4C7D-BBC7-21DAB7454CCBQ31143582-0C13B5A0-3EAB-4711-8B79-52E717CFD7B8Q33646482-0A99BE07-F1A0-4EE4-B4E8-B38C70BE471CQ33883646-0EEB2B7E-9CC5-4D29-9536-3C50AB257896Q38748387-7A4699F3-CF38-4B99-8C27-181514C7468DQ38854076-283B120A-92A3-4455-BF95-8F599FDF50E1Q39040719-4D918A88-C92C-4F80-92D9-637F88D8E93BQ40118666-3502B878-99D5-4026-BCBF-ECED0C60CD98Q40285894-A8586B5D-79B4-4B08-8442-BE01EB0918B5Q40355278-DFC3869D-E5FB-4895-B94B-095B690D2E0BQ40567336-3F424A40-1B09-450D-9BAE-23F00CD40219Q40576603-16D4055F-F00F-4ED8-9141-3816C4ED0054Q41923104-ADD79BA4-2DEC-48E5-A7F3-A27BD9A16DF5Q47595176-33708390-ADCF-4D7E-BA81-3D92A3F660E4Q54216603-3DF3D734-8D3A-489E-8433-8826E2610FAAQ54256586-93CB2760-D5B9-4875-86DA-B560A6B32CF4Q55020469-6E31E301-20B2-4497-A100-BB97F014DB74Q56395991-530C81CD-7E00-4C56-BC86-70668F4C4881Q57841241-D5A46CE4-FB27-4053-BD31-B67CDC544318
P2860
Comparative effectiveness of ledipasvir/sofosbuvir ± ribavirin vs. ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in 6961 genotype 1 patients treated in routine medical practice.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Comparative effectiveness of l ...... d in routine medical practice.
@en
Comparative effectiveness of l ...... d in routine medical practice.
@nl
type
label
Comparative effectiveness of l ...... d in routine medical practice.
@en
Comparative effectiveness of l ...... d in routine medical practice.
@nl
prefLabel
Comparative effectiveness of l ...... d in routine medical practice.
@en
Comparative effectiveness of l ...... d in routine medical practice.
@nl
P2093
P2860
P356
P1476
Comparative effectiveness of l ...... ed in routine medical practice
@en
P2093
P S Belperio
T A Shahoumian
T P Loomis
P2860
P304
P356
10.1111/APT.13696
P407
P577
2016-06-13T00:00:00Z